150 related articles for article (PubMed ID: 2294129)
1. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT
J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay.
Baker ML; Metcalfe SA; Hutson JM
J Clin Endocrinol Metab; 1990 Jan; 70(1):11-5. PubMed ID: 2403569
[TBL] [Abstract][Full Text] [Related]
3. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.
Lee MM; Donahoe PK; Hasegawa T; Silverman B; Crist GB; Best S; Hasegawa Y; Noto RA; Schoenfeld D; MacLaughlin DT
J Clin Endocrinol Metab; 1996 Feb; 81(2):571-6. PubMed ID: 8636269
[TBL] [Abstract][Full Text] [Related]
4. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.
Gustafson ML; Lee MM; Asmundson L; MacLaughlin DT; Donahoe PK
J Pediatr Surg; 1993 Mar; 28(3):439-44. PubMed ID: 8468660
[TBL] [Abstract][Full Text] [Related]
5. An enzyme linked immunoassay for anti-müllerian hormone: a new tool for the evaluation of testicular function in infants and children.
Josso N; Legeai L; Forest MG; Chaussain JL; Brauner R
J Clin Endocrinol Metab; 1990 Jan; 70(1):23-7. PubMed ID: 1688440
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life.
Baker ML; Hutson JM
J Clin Endocrinol Metab; 1993 Jan; 76(1):245-7. PubMed ID: 8421093
[TBL] [Abstract][Full Text] [Related]
7. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.
Misra M; MacLaughlin DT; Donahoe PK; Lee MM
J Clin Endocrinol Metab; 2002 Aug; 87(8):3598-602. PubMed ID: 12161481
[TBL] [Abstract][Full Text] [Related]
8. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT
N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766
[TBL] [Abstract][Full Text] [Related]
9. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
Lee MM; Donahoe PK
Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
[TBL] [Abstract][Full Text] [Related]
10. The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.
Misra M; MacLaughlin DT; Donahoe PK; Lee MM
J Clin Endocrinol Metab; 2003 Feb; 88(2):787-92. PubMed ID: 12574214
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay.
Long WQ; Ranchin V; Pautier P; Belville C; Denizot P; Cailla H; Lhommé C; Picard JY; Bidart JM; Rey R
J Clin Endocrinol Metab; 2000 Feb; 85(2):540-4. PubMed ID: 10690852
[TBL] [Abstract][Full Text] [Related]
12. Detection of Müllerian inhibiting substance in biological samples by a solid phase sandwich radioimmunoassay.
Necklaws EC; LaQuaglia MP; MacLaughlin D; Hudson P; Mudgett-Hunter M; Donahoe PK
Endocrinology; 1986 Feb; 118(2):791-6. PubMed ID: 3753678
[TBL] [Abstract][Full Text] [Related]
13. Serum müllerian-inhibiting substance levels during normal menstrual cycles.
Cook CL; Siow Y; Taylor S; Fallat ME
Fertil Steril; 2000 Apr; 73(4):859-61. PubMed ID: 10731554
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of müllerian inhibiting substance in preterm and term male neonates.
Schwindt B; Doyle LW; Hutson JM
J Urol; 1997 Aug; 158(2):610-2. PubMed ID: 9224378
[TBL] [Abstract][Full Text] [Related]
15. The relationship between müllerian inhibiting substance and androgens in boys with hypospadias.
Austin PF; Siow Y; Fallat ME; Cain MP; Rink RC; Casale AJ
J Urol; 2002 Oct; 168(4 Pt 2):1784-8; discussion 1788. PubMed ID: 12352359
[TBL] [Abstract][Full Text] [Related]
16. [Antimullerian hormone in clinical human applications].
Josso N; Rey R
Contracept Fertil Sex; 1994 Oct; 22(10):661-3. PubMed ID: 7804385
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of Mullerian inhibiting substance in boys with cryptorchidism.
Yamanaka J; Baker M; Metcalfe S; Hutson JM
J Pediatr Surg; 1991 May; 26(5):621-3. PubMed ID: 1676417
[TBL] [Abstract][Full Text] [Related]
18. Sex-specific fetal lung development and müllerian inhibiting substance.
Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
[TBL] [Abstract][Full Text] [Related]
19. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
[TBL] [Abstract][Full Text] [Related]
20. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
